Anti-Helicobacter pylori drugs must be considered as first line therapy in peptic ulcer
Mincis, M.
Amb Revista da Associacao Medica Brasileira 37(1): 51-52
1991
ISSN/ISBN: 0102-843X PMID: 1658869 Document Number: 374835
Document emailed within 1 workday
Related Documents
Vestergård, A.; Bredahl, K.; de Muckadell, O.B.S.; Pedersen, O.B.; Hansen, J.M.øl. 2009: Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid Ugeskrift for Laeger 171(4): 235-239Chung, S.Jin.; Lee, D.Ho.; Kim, N.; Jung, S.Hyang.; Kim, J.Wook.; Hwang, J.Hyeok.; Park, Y.Soo.; Lee, K.Hyuk.; Jung, H.Chae.; Song, I.Sung. 2007: Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease Hepato-Gastroenterology 54(76): 1293-1296
Köksal, H. 1993: The role of Helicobacter pylori in the etiology of peptic ulcer and its therapy Mikrobiyoloji Bulteni 27(3): 266-270
Satoh, K.; Sugano, K. 2009: Helicobacter pylori eradication therapy for peptic ulcer disease Nihon Rinsho. Japanese Journal of Clinical Medicine 67(12): 2322-2326
Grigor'ev, P.Ia.; Iakovenko, A.V.; Vasil'ev, I.V. 1995: Gastrotsepin in the therapy and prevention of peptic ulcer exacerbations associated with Helicobacter pylori bacteriosis Klinicheskaia Meditsina 73(1): 50-52
Boixeda De Miquel, D.; Martín De Argila, C. 2002: Current therapy of Helicobacter pylori infection in peptic ulcer disease (first part) Revista Clinica Espanola 202(9): 492-494
Kullavanijaya, P.; Gonlachanvit, S.; Mahachai, V.; Kladchareon, N. 2000: Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease Journal of the Medical Association of Thailand 83(3): 230-235
Zerbib, F. 1998: Helicobacter pylori et anti-inflammatoires non stéroïdiens Helicobacter pylori et reflux gastro-œsophagien - Helicobacter pylori and NSAID. Helicobacter pylori in GORD Hepato-Gastro (Montrouge) 5(FEV): 56-60
Ohkusa, T.; Watanabe, M. 2001: A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 59(2): 323-327
Ching, C.K.; Wong, B.C.; Kwok, E.; Ong, L.; Covacci, A.; Lam, S.K. 1996: Prevalence of CagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls American Journal of Gastroenterology 91(5): 949-953
Bauerfeind, P.; Wirth, H.P. 1997: Peptic ulcer, Helicobacter pylori Therapeutische Umschau. Revue Therapeutique 54(11): 624-628
Blum, A.L. 1996: Helicobacter pylori and peptic ulcer disease Scandinavian Journal of Gastroenterology. Suppl 214: 24-27; Discussion: 42-43
León-Barúa, R.; Recavarren-Arce, S. 1992: Helicobacter pylori, gastritis, and peptic ulcer Acta Gastroenterologica Latinoamericana 22(1): 61-62
Kühneck, W. 1993: Helicobacter pylori infection and peptic ulcer Deutsche Medizinische Wochenschrift 118(48): 1783-1784
Ballesteros Amozurrutia, M.A. 2003: Helicobacter pylori and peptic ulcer hemorrhage Revista de Gastroenterologia de Mexico 68(Suppl 3): 60-62
Buzás, G.M.; Székely, E. 1999: Eradication of Helicobacter pylori in peptic ulcer patients Orvosi Hetilap 140(3): 121-124
Narayanan, M.; Reddy, K.M.; Marsicano, E. 2018: Peptic Ulcer Disease and Helicobacter pylori infection Missouri Medicine 115(3): 219-224
Partipilo, M.L.; Woster, P.S. 1993: The role of Helicobacter pylori in peptic ulcer disease PharmacoTherapy 13(4): 330-339
Ohara, T.; Kanoh, Y.; Higuchi, K.; Arakawa, T.; Morisita, T. 2003: Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy Hepato-Gastroenterology 50(51): 607-609
Lokhvitskiĭ, S.V.; Darvin, V.V.; Proshin, A.V.; Bashirova, E.S.; Butorov, I.L. 1998: Evaluation of results of surgical treatment of peptic ulcer associated with Helicobacter pylori Vestnik Khirurgii Imeni I. I. Grekova 157(2): 18-20